CN105148867A - Graphene oxide-recombined streptococcal protein G non-covalent composite material as well as preparation method and application thereof - Google Patents
Graphene oxide-recombined streptococcal protein G non-covalent composite material as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN105148867A CN105148867A CN201510582222.3A CN201510582222A CN105148867A CN 105148867 A CN105148867 A CN 105148867A CN 201510582222 A CN201510582222 A CN 201510582222A CN 105148867 A CN105148867 A CN 105148867A
- Authority
- CN
- China
- Prior art keywords
- graphene oxide
- covalent
- composite
- protein
- graphene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 229910021389 graphene Inorganic materials 0.000 title claims abstract description 48
- 239000002131 composite material Substances 0.000 title claims abstract description 31
- 108700011201 Streptococcus IgG Fc-binding Proteins 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 29
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000011091 antibody purification Methods 0.000 claims abstract description 3
- 239000012472 biological sample Substances 0.000 claims abstract description 3
- 230000004913 activation Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 5
- 244000052769 pathogen Species 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 230000001717 pathogenic effect Effects 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 230000010355 oscillation Effects 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 101710120037 Toxin CcdB Proteins 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 229940027941 immunoglobulin g Drugs 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 101710153593 Albumin A Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention relates to a graphene oxide-recombined streptococcal protein G non-covalent composite material as well as a preparation method and application thereof. A recombined streptococcal protein G is immobilized on a graphene oxide material by making use of the characteristic that graphene oxide is high in specific surface area by a non-covalent combination method so as to prepare a high-capacity antibody-enriched material with antibody adsorption bioactivity. The prepared graphene oxide-recombined streptococcal protein G non-covalent composite material can be used in the fields of antibody purification, antibody enrichment, pathogene detection, biological sample pretreatment and the like.
Description
Technical field
The invention belongs to chemosynthesis technical field, relate to graphene composite material technology of preparing and the application in protein-enriched thereof, specifically a kind of preparation based on graphene oxide-non-covalent composite of restructuring streptococcus protein G and functionalized application thereof.
Background technology
Infectious disease pathogens itself can produce corresponding special antibody as antigen in living organism, specific recognition between mostly existing detection method is by Ag-Ab detects pathogen, as Enzyme-linked Immunosorbent Assay technology, immunofluorescence and immune colloidal gold technique etc.These immunological techniques have easy and simple to handle, and result is easy to the features such as analysis, but the sensitivity of immunological detection method is relatively low, easily cause the false negative of result.In order to improve the detection sensitivity of immunological detection method to infectious disease pathogens, usually take by carrying out enrichment to sample.Effective pre-treatment is carried out to sample, the concentration of antibody in detected sample can be improved, thus indirectly improve the sensitivity of detection method.Be at present the restructuring streptococcus protein G of the immobilized adsorb antibodies of carrier mainly with agarose, trehalose for the commercial reagents of antibody enrichment, ProteinG as immobilized in agarose is about 80ug/mL, and its immobilized protein content is lower.Therefore develop the carrier large to target protein supported quantity, and by effective immobilized restructuring streptococcus protein G, antibody enrichment is significant for realizing.
Graphene is a kind of two-dimension nano materials only having a carbon atom thickness, is the flat film of the hexagonal honeycomb lattice that carbon atom forms with SP2 hybridized orbit.2004 by Novoselov etc. with adhesive tape layer by layer stripping method be separated from graphite and obtain, its theoretic throat is only 0.335nm.Single-layer graphene becomes the Novel Carbon Nanomaterials after CNT, has started huge research boom in various fields such as physics, chemistry, material, biologies.Without carbon atom disappearance in Graphene, mechanical strength is high, Stability Analysis of Structures, Heat stability is good, chemical stability are high, the large (2600m of specific area
2g
-1), and there is good biocompatibility, make its easily absorption other biological molecule, particularly graphene oxide is except having bigger serface, a large amount of oxy radicals is also there is on its surface, graphene oxide is made to be more suitable for the biomolecule of adsorbing and having more chemical group, as protein, nucleic acid etc.When grapheme material and other materials phase compound tense, utilize the relevant nature of other materials, the enrichment of biomolecule can be realized.
Summary of the invention
In view of this, the present invention utilizes the characteristic of the high-specific surface area of graphene oxide, by the method for Non-covalent binding, streptococcus protein G (PG) of recombinating is immobilized to graphene oxide (GO) material, prepares the high power capacity antibody enrichment material with antibody adsorbed bioactive.Concrete technical scheme is as follows.
The graphene oxide that the application provides-non-covalent composite of restructuring streptococcus protein G is attached most importance to the Non-covalent binding thing of group of streptococcus Protein G and graphene oxide, and described graphene oxide is 1:2.5-3 with the ratio of the mass number of restructuring streptococcus protein G.
Described in the application, the preparation method of non-covalent composite comprises the steps:
1) active oxidation Graphene (GO);
2) proportionally, active oxidation Graphene (GO) is mixed with restructuring streptococcus protein G (PG), and carries out oscillation incubation, after centrifugal, remove supernatant, material washs, and resulting materials is graphene oxide-non-covalent composite of restructuring streptococcus protein G (GOPG).
Further, above-mentioned steps 1) described in the step of active oxidation Graphene be: be resuspended in by graphene oxide in deionized water, room temperature is ultrasonic will fully disperse; Activate after adding 8-12 part N-hydroxysuccinimide (NHS) and 2-4 part 1-(3-dimethylamino-propyl)-3-ethyl-carbodiimide hydrochloride (EDC) mixing in 1 part of graphene oxide composite material simultaneously; After detergent, obtain the graphene oxide of activation.
Further, the application of graphene oxide-non-covalent composite of restructuring streptococcus protein G in antibody purification, antibody enrichment, pathogen detection and/or biological sample pretreatment process field that provide of the application.
tool of the present invention has the following advantages:
1. the present invention optimizes the immobilized condition of graphene oxide composite material counterweight group of streptococcus albumin A, maintains the activity of albumen, and improves the supported quantity of albumen;
2. the preparation process of the method easy, be easy to promote, favorable reproducibility;
3. the method is prepared graphene oxide-restructuring streptococcal protein A composite and is easy to large-scale production, and cost is low.
Accompanying drawing explanation
Fig. 1. prepare material MALDI and detect;
Fig. 2. prepare Materials Antibodies absorption and detect.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
embodiment 1
(1) activation of graphene oxide (GO)
1.1mgGO is resuspended in the deionized water of 1mL, and the ultrasonic 3h of room temperature, fully disperses;
2. add 500mM2-(N-morpholinyl) ethyl sulfonic acid 4-morpholino b acid (pH6.1) (MES) 500 μ L, 16mg/mlNHS500 μ L and 4mg/mlEDC500uL while of then, mixing, room temperature rapid stirring 30min;
3. material 500mM(pH6.1) MES cyclic washing, NHS and EDC that removing is remaining, final volume is 1mL;
4. solution is the GO of activation.
(2) the immobilized restructuring streptococcus protein G of graphene oxide
1. select the ratio according to 1:2.5, material GO and the PG above-mentioned () prepared mixes, and carries out 4 DEG C of shaken overnight and hatches;
Removing supernatant after 2.16400 × g/10min is centrifugal, add 500mM(pH6.1) MES washs three times, and resulting materials is graphene oxide-restructuring streptococcus protein G (GOPG) non-covalent composite.
(3) support material property of protein detects
Obtained material carries out MALDI detection, result as shown in Figure 1: figure A is GOPG, and figure B is PG, PG molecular weight is 31KD, is PG peak at 15527 places, and all the other are peak of mixing.Albumen immobilized in illustrative material is PG.
(4) support material Function detection
By the non-covalent composite of GOPG of preparation after bovine serum albumin(BSA) is closed, the immunoglobulin G (IgG) marked with fluorescein isothiocynate (FITC) hatches 2h, observed by inverted fluorescence microscope, as shown in Figure 2, A figure is white light field, irregular material is GO-PG composite, B figure is the green fluorescence field of relevant position, visible by left and right contrast under 400 times of visuals field, GOPG non-covalent composite periphery has obvious luciferase expression, illustrate that the IgG that FITC marks is attracted on material, on the non-covalent composite of prompting GOPG, the activity of Protein G keeps good.
embodiment 2
In the activation protocol of graphene oxide (GO), NHS concentration changes 24mg/ml into, and other are with embodiment 1, can be prepared into the non-covalent composite of GOPG.
embodiment 3
In the activation protocol of graphene oxide (GO), NHS concentration changes 20mg/ml into, and other are with embodiment 1, can be prepared into the non-covalent composite of GOPG.
embodiment 4
In the activation protocol of graphene oxide (GO), EDC concentration changes 8mg/ml into, and other are with embodiment 1, can be prepared into the non-covalent composite of GOPG.
embodiment 5
In the activation protocol of graphene oxide (GO), EDC concentration changes 6mg/ml into, and other are with embodiment 1, can be prepared into the non-covalent composite of GOPG.
embodiment 6
In graphene oxide immobilized restructuring streptococcus protein G scheme, ratio is adjusted to 1:3, and other are with embodiment 1, can be prepared into the non-covalent composite of GOPG.
embodiment 7
In graphene oxide immobilized restructuring streptococcus protein G scheme, ratio is adjusted to 1:2.8, and other are with embodiment 1, can be prepared into the non-covalent composite of GOPG.
embodiment 8
GOPG material Protein G supported quantity is analyzed.Under the immobilized condition of embodiment 1, utilize BCA protein quantification principle, measure the Protein G content that rear different time supernatant is hatched in material GO and PG mixing, the supported quantity that indirectly can record material Protein G is 3.38mg/mg.
embodiment 9
GOPG material Protein G supported quantity is analyzed.Under the immobilized condition of embodiment 2-embodiment 7, utilize BCA protein quantification principle, measure the Protein G content that rear different time supernatant is hatched in material GO and PG mixing, indirectly can record the supported quantity of material Protein G between 1mg/mg-4mg/mg, compare with the immobilized ProteinG80ug/mL of commercially available reagent agarose, its supported quantity improves greatly.
The above; be only the specific embodiment of the present invention, but protection scope of the present invention is not limited thereto, is anyly familiar with those skilled in the art in the technical scope that the present invention discloses; change can be expected easily or replace, all should be encompassed within protection scope of the present invention.Therefore, protection scope of the present invention should described be as the criterion with the protection domain of claim.
Claims (4)
1. graphene oxide-non-covalent composite of restructuring streptococcus protein G, it is characterized in that, described composite is attached most importance to the Non-covalent binding thing of group of streptococcus Protein G and graphene oxide, and described graphene oxide is 1:2.5-3 with the ratio of the mass number of restructuring streptococcus protein G.
2. a preparation method for non-covalent composite according to claim 1, is characterized in that, comprise the steps:
1) active oxidation Graphene;
2) proportionally, mixed with restructuring streptococcus protein G by active oxidation Graphene, and carry out oscillation incubation, remove supernatant after centrifugal, material washs, and resulting materials is graphene oxide-non-covalent composite of restructuring streptococcus protein G.
3. follow the preparation method according to non-covalent composite according to claim 2, it is characterized in that, described in step 1), the step of active oxidation Graphene is: be resuspended in by graphene oxide in deionized water, and room temperature is ultrasonic will fully disperse; Activate after adding 8-12 part N-hydroxysuccinimide and the mixing of 2-4 part 1-(3-dimethylamino-propyl)-3-ethyl-carbodiimide hydrochloride in 1 part of graphene oxide composite material simultaneously; After detergent, obtain the graphene oxide of activation.
4. the graphene oxide according to claim 1-application of the non-covalent composite of restructuring streptococcus protein G in antibody purification, antibody enrichment, pathogen detection and/or biological sample pretreatment process.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510582222.3A CN105148867A (en) | 2015-09-15 | 2015-09-15 | Graphene oxide-recombined streptococcal protein G non-covalent composite material as well as preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510582222.3A CN105148867A (en) | 2015-09-15 | 2015-09-15 | Graphene oxide-recombined streptococcal protein G non-covalent composite material as well as preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105148867A true CN105148867A (en) | 2015-12-16 |
Family
ID=54790086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510582222.3A Pending CN105148867A (en) | 2015-09-15 | 2015-09-15 | Graphene oxide-recombined streptococcal protein G non-covalent composite material as well as preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105148867A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1956779A (en) * | 2004-05-24 | 2007-05-02 | 株式会社资生堂 | Affinity Particles and Affinity Separation Methods |
| WO2009010877A2 (en) * | 2007-07-17 | 2009-01-22 | Novartis Ag | Conjugate purification |
| CN103418348A (en) * | 2013-08-27 | 2013-12-04 | 湖南大学 | Oxidized graphene-rhamnolipid composite material and preparation method and application thereof |
| CN103732533A (en) * | 2011-05-19 | 2014-04-16 | 纽约城市大学研究基金会 | Chemically modified graphene |
| CN103861565A (en) * | 2012-12-14 | 2014-06-18 | 吉首大学 | Preparation of linear amino modified graphene oxide adsorption material |
-
2015
- 2015-09-15 CN CN201510582222.3A patent/CN105148867A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1956779A (en) * | 2004-05-24 | 2007-05-02 | 株式会社资生堂 | Affinity Particles and Affinity Separation Methods |
| WO2009010877A2 (en) * | 2007-07-17 | 2009-01-22 | Novartis Ag | Conjugate purification |
| CN103732533A (en) * | 2011-05-19 | 2014-04-16 | 纽约城市大学研究基金会 | Chemically modified graphene |
| CN103861565A (en) * | 2012-12-14 | 2014-06-18 | 吉首大学 | Preparation of linear amino modified graphene oxide adsorption material |
| CN103418348A (en) * | 2013-08-27 | 2013-12-04 | 湖南大学 | Oxidized graphene-rhamnolipid composite material and preparation method and application thereof |
Non-Patent Citations (5)
| Title |
|---|
| 刘锦斌: ""石墨烯的非共价生物分子修饰用于自组装构造纳米杂化结构的研究"", 《万方数据知识服务平台》 * |
| 孙彤: ""氧化石墨烯的合成、表征、功能化及其与生物大分子相互作用和生物相容性研究"", 《万方数据知识服务平台》 * |
| 程玉鹏等: "《生物技术制药实验指南》", 30 September 2014, 中国农业科学技术出版社 * |
| 陈小乙: ""石墨烯的功能化改性及应用研究"", 《万方数据知识服务平台》 * |
| 陈志南: "《细胞工程》", 30 August 2005, 科学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tang et al. | A review on advances in methods for modification of paper supports for use in point-of-care testing | |
| Shakeri et al. | Biofunctionalization of glass‐and paper‐based microfluidic devices: a review | |
| Sproß et al. | Monolithic media for applications in affinity chromatography | |
| Zhang et al. | Novel magnetic bovine serum albumin imprinted polymers with a matrix of carbon nanotubes, and their application to protein separation | |
| JP2006517985A5 (en) | ||
| Wang et al. | Immunoassay for cardiac troponin I with fluorescent signal amplification by hydrolyzed coumarin released from a metal–organic framework | |
| Bodelón et al. | Nickel nanoparticle-doped paper as a bioactive scaffold for targeted and robust immobilization of functional proteins | |
| CN103506093B (en) | Magnetic dual-template protein molecule imprinted nano particle and preparation method thereof | |
| CN103910836B (en) | Preparation method of magnetic carbon nano-tube surface molecular imprinting polymer for biological sample pretreatment | |
| JP2015535344A5 (en) | ||
| CN103157447B (en) | High-affinity dendroid boric acid functionalized magnetic microsphere and its preparation method and application | |
| CN114814215B (en) | Pathogenic microorganism detection test paper strip based on aptamer latex particles | |
| CN102411051A (en) | Immunodetection method for organophosphorus pesticide multi-residue | |
| CN103592437A (en) | Immunosensor based on modification of graphene-multiwalled carbon-nanogold size-chitosan | |
| Song et al. | Rapid measurement of residual kanamycin using highly specific biomimetic recognition paper-based chip | |
| Xu et al. | Carbon-decorated TiO2 nanotube membranes: a renewable nanofilter for charge-selective enrichment of proteins | |
| Xu et al. | Sandwich-type colorimetric assay based on molecularly imprinted polymers and boronic acid functionalized Ni-Fe-MOF nanozyme for sensitive detection of allergen ovalbumin | |
| CN101382542A (en) | A method for detecting microcystin-LR by immunofluorescence PCR | |
| CN101498719A (en) | Production method for enzyme functionalized nano immunity marker and use thereof | |
| CN103575875A (en) | Novel functionalized gold nanorod immune probe as well as preparation method and application of gold nanorod biological chip | |
| CN103333299B (en) | Glycidyl methacrylate and PEG alkylmethacrylate polymer microballoon and its preparation method and application | |
| CN103694358B (en) | Locus specificity biotin labeling restructuring IgG affinity peptide and the application fixed at three-dimensional orientation in IgG antibody thereof | |
| Militano et al. | Development of biohybrid immuno-selective membranes for target antigen recognition | |
| CN105148867A (en) | Graphene oxide-recombined streptococcal protein G non-covalent composite material as well as preparation method and application thereof | |
| CN103645316A (en) | Streptavidin functionalized semiconductor nano material-based tumor marker electrochemical immunosensor and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151216 |